Skip to main content
. 2015 Sep 10;6(33):35087–35094. doi: 10.18632/oncotarget.5197

Figure 1. PFS (a) and OS (b) according to LDH serum values in a common practice population.

Figure 1

132 advanced pancreatic cancer patients receiving a first line chemotherapy at our Institution from 2008 to 2012 were analysed. LDH ≤ UNR (99 patients) vs. LDH > UNR (33 patients): PFS 4.3 vs. 2.3 months, p = 0.0105; OS 8.6 vs. 3.9 months, p = 0.0042.